The Latest Breaking News from EC

Acting on a complaint forwarded by the Election Commission of India, the News Broadcasting and Digital Standards Authority issued a warning to News18 India for giving a communal colour to a programme on comments made by various political leaders on the occasion of Ram Navami last year. 

The recent amendment prevents the public inspection of electronic documents, including CCTV footage, webcasting recordings, and video footage of candidates. Read further on Dynamite News:

This week on Hafta, Newslaundry’s Abhinandan Sekhri, Jayashree Arunachalam and Shardool Katyayan are joined by journalist Nidhi Razdan and economist and writer Vivek Kaul.

The White House's new restrictions on global AI chip sales would make it harder for the EU to acquire and use them.

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more.

This week on Hafta, Newslaundry’s Abhinandan Sekhri, Jayashree Arunachalam, and Manisha Pande are joined by author Amitava Kumar and academic Joyojeet Pal.

In the past few weeks, you’ve likely heard a lot – and will continue to hear a lot – about votes being “deleted” and “added” from the electoral rolls, allegedly favouring one political party over another. 

The biotech industry is booming thanks to the rising demand for personalized medicine, investment in innovations, and ongoing advancements like AI. Therefore, fundamentally sound biotech stocks Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and Gilead Sciences (GILD), which are at the forefront of innovation, could be ideal portfolio additions. Read more.

While posting the hearing on February 4, the bench said it would see whose views had supremacy. Read further on Dynamite News: